Lupin Enters China with Affordable Flu Treatment

Lupin, a major pharmaceutical company from India, has just received approval to sell its Oseltamivir phosphate oral suspension in China. This move, in partnership with Yabao Pharmaceuticals, marks Lupin's debut in the Chinese market and aims to provide an affordable flu treatment especially for children. What does it mean for you? If you’re in China, it means more access to flu treatments for kids and a potentially cheaper option for keeping those pesky flu bugs at bay. For everyone else, it’s a sign of Lupin’s growing global influence in making healthcare more accessible.